Noelle K. LoConte, MD Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Dr. LoConte is an associate professor of medicine at the University of Wisconsin. She completed medical school at the University of Illinois at Chicago, then did her internship in internal medicine at UW. Dr. LoConte completed her internal medicine residency at Oregon Health Sciences University in Portland. She has also completed fellowship training in both medical oncology as well as geriatrics. She joined the faculty of the UW Carbone Cancer Center in the summer of 2006. She is the recipient of the American Society of Clinical Oncology Young Investigator Award for 2006, and has funding from the Centers for Disease Control and the National Cancer Institute. She has been a principal investigator on many clinical trials of new chemotherapies for gastrointestinal cancers, from Phase I through Phase III studies. Dr. LoConte is also the co-leader of the UW Carbone Cancer Center gastrointestinal disease oriented working group. Dr. LoConte's clinical interests are in gastrointestinal cancers, including liver and pancreas cancers, as well as cancer of any type in the older adult.
UW Health Clinics
UW School of Medicine and Public Health
|Department of Medicine|
Professional Certifications and Education
University of Wisconsin Hospital and Clinics, Madison, WI
Oregon Health Sciences University, Portland
University of Wisconsin Hospital and Clinics, Madison, WI
University of Illinois, Chicago, 2000
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
Dr. LoConte's research interests are in predictors of chemotherapy toxicity, as well as trials of chemotherapy in older adults and patients with gastrointestinal cancers.
Makielski RJ Lubner SJ Mulkerin DL Traynor AM Groteluschen D Eickhoff J LoConte NK .
A phase II study of sorafenib, oxaliplatin, and 2 days of high-dose capecitabine in advanced pancreas cancer. Cancer Chemother Pharmacol. 2015 Aug;76(2):317-23
[PubMed ID: 26068189]
LoConte NK Razak AR Ivy P Tevaarwerk A Leverence R Kolesar J Siu L Lubner SJ Mulkerin DL Schelman WR Deming DA Holen KD Carmichael L Eickhoff J Liu G .
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors. Invest New Drugs. 2015 Feb;33(1):169-76
[PubMed ID: 25318436]
LoConte NK Deming DA .
Mailed invitations for colorectal screening are effective in increasing screening participation in uninsured adults with faecal immunochemical testing: the preferred screening modality. Evid Based Med. 2014 Aug;19(4):145
[PubMed ID: 24727711]
Weiss JM Schumacher J Allen GO Neuman H Lange EO Loconte NK Greenberg CC Smith MA .
Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data. Ann Surg Oncol. 2014 Jun;21(6):1781-91
[PubMed ID: 24643898]
Schmocker RK Caretta-Weyer H Weiss JM Ronk K Havlena J Loconte NK Decker M Smith MA Greenberg CC Neuman HB .
Determining breast cancer axillary surgery within the surveillance epidemiology and end results-Medicare database. J Surg Oncol. 2014 Jun;109(8):756-9
[PubMed ID: 24643795]
Neuman HB Weiss JM Schrag D Ronk K Havlena J LoConte NK Smith MA Greenberg CC .
Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors. Ann Surg Oncol. 2013 Dec;20(13):4128-36
[PubMed ID: 23943027]
LoConte NK Weeth-Feinstein L Conlon A Scott S .
Engaging health systems to increase colorectal cancer screening: community-clinical outreach in underserved areas of Wisconsin. Prev Chronic Dis. 2013 Nov 21;10:E192
[PubMed ID: 24262024]
LoConte NK Holen KD Schelman WR Mulkerin DL Deming DA Hernan HR Traynor AM Goggins T Groteluschen D Oettel K Robinson E Lubner SJ .
A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study. Invest New Drugs. 2013 Aug;31(4):943-8
[PubMed ID: 23263993]
Neuman HB Weiss JM Leverson G O'Connor ES Greenblatt DY Loconte NK Greenberg CC Smith MA .
Predictors of short-term postoperative survival after elective colectomy in colon cancer patients ≥ 80 years of age. Ann Surg Oncol. 2013 May;20(5):1427-35
[PubMed ID: 23292483]
Cetnar J Wilding G McNeel D LoConte NK McFarland TA Eickhoff J Liu G .
A phase 1/1b study of satraplatin (JM-216) in combination with docetaxel in patients with advanced solid tumors and metastatic castrate-resistant prostate cancer. Urol Oncol. 2013 May;31(4):436-41
[PubMed ID: 21481618]
Neuman HB O'Connor ES Weiss J Loconte NK Greenblatt DY Greenberg CC Smith MA .
Surgical treatment of colon cancer in patients aged 80 years and older : analysis of 31,574 patients in the SEER-Medicare database. Cancer. 2013 Feb 1;119(3):639-47
[PubMed ID: 22893570]
Weiss JM Pfau PR O'Connor ES King J LoConte N Kennedy G Smith MA .
Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results--Medicare data. J Clin Oncol. 2011 Nov 20;29(33):4401-9
[PubMed ID: 21969498]
O'Connor ES Greenblatt DY LoConte NK Gangnon RE Liou JI Heise CP Smith MA .
Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol. 2011 Sep 1;29(25):3381-8
[PubMed ID: 21788561]
O'Mahar SE Campbell TC Hoang T Seo S Kim K Larson MM Marcotte SM LoConte NK Traynor AM .
Phase I study of sunitinib and erlotinib in advanced nonsquamous non-small cell lung cancer. J Thorac Oncol. 2011 May;6(5):951-3
[PubMed ID: 21623267]
Kennedy GD Rajamanickam V O'connor ES Loconte NK Foley EF Leverson G Heise CP .
Optimizing surgical care of colon cancer in the older adult population. Ann Surg. 2011 Mar;253(3):508-14
[PubMed ID: 21169811]
Dennie TW Fleming RA Bowen CJ Dar MM Alberti D Oliver K Loconte N Mulkerin D Holen KD .
A phase I study of capecitabine, oxaliplatin, and lapatinib in metastatic or advanced solid tumors. Clin Colorectal Cancer. 2011 Mar 1;10(1):57-62
[PubMed ID: 21609937]
Lepeak L Tevaarwerk A Jones N Williamson A Cetnar J LoConte N .
Persistence in breast cancer disparities between African Americans and whites in Wisconsin. WMJ. 2011 Feb;110(1):21-5
[PubMed ID: 21473509]
Loconte NK Williamson A Gayle A Weiss J Leal T Cetnar J Mohammed T Tevaarwerk A Jones N .
Increasing Disparity in Colorectal Cancer Incidence and Mortality Among African Americans and Whites: A State's Experience. J Gastrointest Oncol. 2011;2(2):85-92
[PubMed ID: 21712962]
Mohammed TA Holen KD Jaskula-Sztul R Mulkerin D Lubner SJ Schelman WR Eickhoff J Chen H Loconte NK .
A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma. Oncologist. 2011;16(6):835-43
[PubMed ID: 21632454]
Lubner SJ Kunnimalaiyaan M Holen KD Ning L Ndiaye M Loconte NK Mulkerin DL Schelman WR Chen H .
A preclinical and clinical study of lithium in low-grade neuroendocrine tumors. Oncologist. 2011;16(4):452-7
[PubMed ID: 21393344]